RAPT Therapeutics offers a competitive compensation and benefits …ĭiscussion. RAPT Therapeutics Announces Pricing of Public Offering of Common Stock. Investors typically determine Rapt Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. RAPT: Get the latest RAPT Therapeutics stock price and detailed information including RAPT news, historical charts and realtime prices. What this means: Rapt Therapeutics Inc (RAPT) gets an Overall Rank of 64, which is an above average rank under InvestorsObserver's stock ranking system. On average, they expect RAPT Therapeutics' stock price to reach $60.17 in the next year.
stock forecast points to a potential upside of 62.98. Rapt Therapeutics (RAPT) Investor Presentation - Slideshow 11/19/21-11:56AM EST Seeking Alpha Kingdon Capital Management, L.l.c. stock holds a sell signal from the short-term moving average at the same time, however, there is a buy signal from the long-term average. is a clinical-stage immunology-based biopharmaceutical company. RAPT Therapeutics Raises $125M Via Equity At 6% Discount. Given the current short-term trend, the stock is expected to rise 2.94% during the next 3 months and, with a 90% probability hold a price between $31.16 and $41.52 at the end of this 3-month period.
MD, Ghost Tree Capital LLC, VR Adviser LLC, Ikarian Capital LLC, Morgan Stanley, Morgan Stanley, Pinz Capital Management LP, and BlackRock Inc. RAPT stock was purchased by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. RAPT Therapeutics has a market capitalization of US$1.0b, so we would expect some institutional investors to have noticed the stock. Thomas Smith, an analyst … Please note that any opinions, estimates or forecasts regarding Galera Therapeutics's performance made by these analysts are theirs alone and … Roth Capital has the highest price target set, predicting RAPT will reach $72.00 in the next twelve months.